Upregulation of Angiotensin II Type 1 Receptor Gene Expression in Chronic Renovascular Hypertension

J. Gregory Modrall, Manuel J. Quinones, Joseph H. Frankhouse, Willa A. Hsueh, Fred A. Weaver, Larry Kedes

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

Although the renin-angiotensin system has been implicated in the pathogenesis of renovascular hypertension (RVH), blood pressure does not parallel serum levels of renin or angiotensin II (AII) in chronic RVH. Upregulation of angiotensin II type 1 receptor (AT1) gene expression may explain this paradox and clarify the pathogenesis of chronic hypertension in RVH. To investigate this hypothesis, we studied changes in AT1 mRNA levels in rat kidney in a two-kidney, one-clip (2K1C) rat model of RVH. Animals were sacrificed at 1 or 10 weeks postoperatively. Blood pressure was measured with a tail cuff photosensor. Relative gene expression was quantitated by dot blotting total RNA, hybridizing with a cDNA probe for AT1, and quantitating signal intensity with scanning densitometry. A significant increase in blood pressure (BP) was observed at 1 week postoperatively (ΔBP: 2K1C = +24 mm Hg, n = 3; controls = +7 mm Hg, n = 3; P < 0.05), and at this time relative AT1 mRNA levels actually decreased in the clipped kidney (P < 0.05). Hypertension intensified 10 weeks postoperatively (ΔBP: 2K1C = +46 mm Hg, n = 20; controls = -17 mm Hg, n = 7; P < 0.005) and, remarkably, was paralleled by an almost sevenfold upregulation of AT1 mRNA levels in the clipped kidney (P < 0.005) and more than eightfold in the unclipped kidney (P < 0.005) of 2K1C animals. Upregulation of renal AT1 gene expression could lead to increased AT1 receptor production, hypersensitivity to AII, and chronic hypertension in RVH.

Original languageEnglish (US)
Pages (from-to)135-140
Number of pages6
JournalJournal of Surgical Research
Volume59
Issue number1
DOIs
Publication statusPublished - Jul 1995

    Fingerprint

ASJC Scopus subject areas

  • Surgery

Cite this